SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-16-018315
Filing Date
2016-08-03
Accepted
2016-08-02 18:03:18
Documents
50
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgls20160630-10q.htm 10-Q 886171
2 EXHIBIT 3.1 ex-3120160630.htm EX-3.1 25017
3 EXHIBIT 10.1 ex-10120160630.htm EX-10.1 530226
4 EXHIBIT 31.1 ex-31120160630.htm EX-31.1 12059
5 EXHIBIT 31.2 ex-312x20160630.htm EX-31.2 12055
6 EXHIBIT 32.1 ex-321x20160630.htm EX-32.1 11332
  Complete submission text file 0001628280-16-018315.txt   4625135

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rgls-20160630.xml EX-101.INS 785778
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgls-20160630.xsd EX-101.SCH 30458
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgls-20160630_cal.xml EX-101.CAL 51574
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgls-20160630_def.xml EX-101.DEF 130229
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgls-20160630_lab.xml EX-101.LAB 412020
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgls-20160630_pre.xml EX-101.PRE 228146
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 161801727
SIC: 2834 Pharmaceutical Preparations